AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
-26.58%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(-20%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
14.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Spero Therapeutics
SPRO
|
$16.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.06% |
| 2 | Communication Services | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Intellia Therapeutics
NTLA
$1.22B
| $68.8M | 60.94% | 3,579,788 | – | – |
|
2
Synlogic
SYBX
$17M
| $25.7M | 22.78% | 2,651,963 | – | – |
|
|
3
Spero Therapeutics
SPRO
$116M
| $16.2M | 14.33% | +1,376,968 | New | +$16.2M |
|
4
Snap
SNAP
$12.1B
| $2.19M | 1.94% | 150,160 | – | – |
|